Title:
BOTANICAL MEDICINE FOR TREATING HYPERLIPIDEMIA AND CORONARY HEART DISEASE AND METHOD FOR PREPARATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/078295
Kind Code:
A1
Abstract:
Provided are a botanical medicine for treating hyperlipidemia and coronary heart disease and a method for preparation thereof, comprising the following raw materials in parts by weight: 20-25 parts of Ginkgo biloba extract, 10-12 parts of Agaricus blazei powder, 5-8 parts of pea flour, 3-5 parts of Radix Pseudostellariae, 3-5 parts of Szechuan lovage, 10-15 parts of Fructus Gardeniae oil, 2-3 parts of Semen cassiae, 5-8 parts of Astragalus, 5-8 parts of Salvia miltiorrhiza, 3-5 parts of Angelica sinensis, 3-5 parts of yeast glucan, 2-3 parts of Rehmanniae radix preparata, 5-8 parts of linseed oil, 1-2 parts of Chinese wolfberry, 2-3 parts of onion extract, and 5-8 parts of xylitol. The medicine is rationally compounded with Ginkgo biloba extract, Fructus Gardeniae oil, and other components which have the effect of reducing blood sugar and lipids, to achieve the effects of lowering blood lipids, improving blood circulation, thrombolysis, preventing and treating atherosclerosis, and losing weight and slimming.
Inventors:
HE JINGREN (CN)
LI YUBAO (CN)
LI YUBAO (CN)
Application Number:
PCT/CN2020/123559
Publication Date:
April 29, 2021
Filing Date:
October 26, 2020
Export Citation:
Assignee:
GUOZHONGXINGHE BIOMEDICINE TECH CO LTD (CN)
HE JINGREN (CN)
LI YUBAO (CN)
CHINA YUNHONG HOLDINGS CO LTD (CN)
HE JINGREN (CN)
LI YUBAO (CN)
CHINA YUNHONG HOLDINGS CO LTD (CN)
International Classes:
A61K36/16; A61K9/48; A61K36/744; A61P3/06; A61P9/10
Foreign References:
| CN1283497A | 2001-02-14 | |||
| CN1283497A | 2001-02-14 | |||
| CN108992473A | 2018-12-14 | |||
| CN103060078A | 2013-04-24 | |||
| CN111084850A | 2020-05-01 | |||
| CN110694046A | 2020-01-17 |
Other References:
ZHAO, WENLONG ET AL.: "Progress on Extraction and Separation of Ginkgo Flavonoids and Terpene Lactones from Ginkgo biloba L.", PROCEEDINGS OF THE FIRST CHINA SUBCRITICAL BIOLOGICAL EXTRACTION TECHNOLOGY DEVELOPMENT FORUM, 3 December 2016 (2016-12-03), pages 31 - 40, XP055804690
Attorney, Agent or Firm:
FANG & ASSOCIATES (CN)
Download PDF: